Vitamin Blue Stock Revenue
| VTMB Stock | USD 0.0001 0.00 0.00% |
Vitamin Blue fundamentals help investors to digest information that contributes to Vitamin Blue's financial success or failures. It also enables traders to predict the movement of Vitamin Pink Sheet. The fundamental analysis module provides a way to measure Vitamin Blue's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vitamin Blue pink sheet.
Vitamin |
Vitamin Blue Company Revenue Analysis
Vitamin Blue's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Vitamin Blue Revenue | 250.03 K |
Most of Vitamin Blue's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitamin Blue is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Vitamin Blue reported 250.03 K of revenue. This is 100.0% lower than that of the Consumer Cyclical sector and 99.99% lower than that of the Leisure industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Vitamin Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vitamin Blue's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vitamin Blue could also be used in its relative valuation, which is a method of valuing Vitamin Blue by comparing valuation metrics of similar companies.Vitamin Blue is currently under evaluation in revenue category among related companies.
Vitamin Fundamentals
| Return On Asset | -1.4 | |||
| Operating Margin | (0.78) % | |||
| Current Valuation | 766.89 K | |||
| Shares Outstanding | 783.4 M | |||
| Price To Earning | (0.40) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 250.03 K | |||
| Gross Profit | 55.5 K | |||
| EBITDA | (112.37 K) | |||
| Net Income | (21.08 K) | |||
| Cash And Equivalents | 2.52 K | |||
| Total Debt | 307.37 K | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 7.69 K | |||
| Earnings Per Share | (0) X | |||
| Beta | 48.49 | |||
| Market Capitalization | 14.1 K | |||
| Total Asset | 31.72 K | |||
| Retained Earnings | (2.84 M) | |||
| Working Capital | (706 K) | |||
| Current Asset | 30 K | |||
| Current Liabilities | 736 K | |||
| Net Asset | 31.72 K |
About Vitamin Blue Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vitamin Blue's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitamin Blue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitamin Blue based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vitamin Blue in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vitamin Blue's short interest history, or implied volatility extrapolated from Vitamin Blue options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vitamin Blue. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |